These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19622397)

  • 1. TGF-beta and IL-17 serum levels and specific immunotherapy.
    Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
    Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.
    Ciprandi G; De Amici M; Tosca M; Marseglia G
    Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
    Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two year sublingual immunotherapy affects serum leptin.
    Ciprandi G; De Amici M; Tosca M; Negrini S; Murdaca G; Marseglia GL
    Int Immunopharmacol; 2009 Sep; 9(10):1244-6. PubMed ID: 19497390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.
    Ciprandi G; De Amici M; Tosca MA; Pistorio A; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4):1089-96. PubMed ID: 20074473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis.
    Ciprandi G; De Amici M; Murdaca G; Fenoglio D; Ricciardolo F; Marseglia G; Tosca M
    Allergy; 2009 Sep; 64(9):1375-8. PubMed ID: 19226302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy may affect serum neopterin: preliminary findings.
    Ciprandi G; De Amici M; Marseglia G; Fuchs D
    Int Immunopharmacol; 2010 Nov; 10(11):1474-6. PubMed ID: 20863918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IL-4 as a marker of immunological response to sublingual immunotherapy.
    Ciprandi G; De Amici M; Murdaca G; Colombo BM; Quaglini S; Marseglia G; Di Gioacchino M
    J Biol Regul Homeost Agents; 2008; 22(2):117-23. PubMed ID: 18597704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
    Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carry-over effect on IFN-gamma production induced by allergen-specific immunotherapy.
    Ciprandi G; Sormani MP; Filaci G; Fenoglio D
    Int Immunopharmacol; 2008 Dec; 8(12):1622-5. PubMed ID: 18691675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.